Considering the strong abundance of EpCAM in a wide variety of epithelial cancer types, EpCAM-targeted DARPin-based NIRF/PA imaging tracers may be deployed in a broad, pan-carcinoma clinical context. This evidence concerns the gene EPCAM and carcinoma.